RA Capital Management increased its stake in Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) to approximately 9.95 million shares. The stock price climbed $1.05 to $8.46.
RA Capital Management increases stake in Achillion
August 17, 2015 at 14:28 PM EDT
